Filed 27d ago· May 8, 2026
21 days to disclose
Maria Elvira Salazar
RHouseFlorida-27
↓sold
Amgen
AMGN
$15K-$50K
Trade dateApr 17, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–69 of 69
Filed 1mo ago· Apr 21, 2026
28 days to discloseMaria Elvira Salazar
RHouseFlorida-27
↑bought
Amgen
AMGN
$15K-$50K
−7.6% vs S&P 500
Trade dateMar 24, 2026
Filed 3mo ago· Mar 6, 2026
8 days to disclose
David J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−5.7% vs S&P 500
Trade dateFeb 26, 2026
Filed 4mo ago· Feb 2, 2026
4 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
Filed 4mo ago· Feb 2, 2026
17 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Amgen
AMGN
$1K-$15K
+3.8% vs S&P 500
Trade dateJan 16, 2026
Filed 4mo ago· Jan 13, 2026
420 days to disclose · 375 past 45-day window
Julia Letlow
RHouseLouisiana-05
↓sold
Amgen
AMGN
$1K-$15K
+5.2% vs S&P 500
Trade dateNov 19, 2024
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Amgen
AMGN
$1K-$15K
+6.3% vs S&P 500
Trade dateOct 23, 2024
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 6mo ago· Dec 5, 2025
2 days to discloseDavid J. Taylor
RHouseOhio-02
↓sold
Amgen
AMGN
$1K-$15K
−4.2% vs S&P 500
Trade dateDec 3, 2025
Filed 7mo ago· Oct 28, 2025
4 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+11.1% vs S&P 500
Trade dateOct 24, 2025
Filed 7mo ago· Oct 22, 2025
27 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
Amgen
AMGN
$1K-$15K
+10.7% vs S&P 500
Trade dateSep 25, 2025
⚑ Pharmaceutical
Filed 8mo ago· Oct 3, 2025
29 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↓sold
Amgen
AMGN
$1K-$15K
+8.1% vs S&P 500
Trade dateSep 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 27, 2025
16 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.1% vs S&P 500
Trade dateSep 11, 2025
Filed 9mo ago· Aug 20, 2025
190 days to disclose · 145 past 45-day window
Daniel Meuser
RHousePennsylvania-09
↓sold
Amgen
AMGN
$1K-$15K
+1.7% vs S&P 500
Trade dateFeb 11, 2025
Filed 9mo ago· Aug 13, 2025
50 days to disclose · 5 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Amgen
AMGN
$1K-$15K
+8.2% vs S&P 500
Trade dateJun 24, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jul 9, 2025
33 days to disclose
Cliff Bentz
RHouseOregon-02
↑bought
Amgen
AMGN
$1K-$15K
+2.3% vs S&P 500
Trade dateJun 6, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day window
Scott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Amgen
AMGN
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 1.0y ago· May 19, 2025
5 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.1% vs S&P 500
Trade dateMay 14, 2025
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 9, 2025
23 days to disclose
Jared Moskowitz
DHouseFlorida-23
↑bought
Amgen
AMGN
$1K-$15K
+8.1% vs S&P 500
Trade dateApr 16, 2025
Filed 1.1y ago· May 9, 2025
23 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Amgen
AMGN
$1K-$15K
+8.1% vs S&P 500
Trade dateApr 16, 2025
Filed 1.1y ago· May 8, 2025
27 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Amgen
AMGN
$15K-$50K
+7.1% vs S&P 500
Trade dateApr 11, 2025
Filed 1.1y ago· May 8, 2025
30 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Amgen
AMGN
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+10.0% vs S&P 500
Trade dateMay 5, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Amgen
AMGN
$15K-$50K
+6.2% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.3y ago· Feb 11, 2025
36 days to disclose
Emily Randall
DHouseWashington-06
↓sold
Amgen
AMGN
$1K-$15K
+6.8% vs S&P 500
Trade dateJan 6, 2025
Filed 1.4y ago· Jan 6, 2025
31 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↑bought
Amgen
AMGN
$1K-$15K
+18.4% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.6y ago· Oct 10, 2024
23 days to discloseSheldon Whitehouse
DSenateRhode Island
↓sold
Amgen
AMGN
$1K-$15K
+23.3% vs S&P 500
Trade dateSep 17, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 21, 2024
404 days to disclose · 359 past 45-day windowJared Moskowitz
DHouseFlorida-23
↑bought
Amgen
AMGN
$1K-$15K
+32.7% vs S&P 500
Trade dateJul 14, 2023
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$50K-$100K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+1.1% vs S&P 500
Trade dateAug 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+2.6% vs S&P 500
Trade dateJul 2, 2024
Filed 2.3y ago· Feb 14, 2024
26 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Amgen
AMGN
$15K-$50K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
−0.4% vs S&P 500
Trade dateJan 23, 2024
Filed 2.4y ago· Jan 22, 2024
20 days to disclose
Michael C. Burgess
—HouseTexas-26
↓sold
Amgen
AMGN
$15K-$50K
+35.2% vs S&P 500
Trade dateJan 2, 2024
Filed 2.8y ago· Aug 10, 2023
357 days to disclose · 312 past 45-day window
Rick W. Allen
RHouseGeorgia-12
↑bought
Amgen
AMGN
$15K-$50K
−28.9% vs S&P 500
Trade dateAug 18, 2022
⚑ Pharmaceutical
Filed 2.8y ago· Aug 10, 2023
1413 days to disclose · 1368 past 45-day windowRick W. Allen
RHouseGeorgia-12
↑bought
Amgen
AMGN
$15K-$50K
Trade dateSep 27, 2019
⚑ Pharmaceutical
Filed 2.9y ago· Jul 17, 2023
35 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↓sold
Amgen
AMGN
$1K-$15K
+6.1% vs S&P 500
Trade dateJun 12, 2023
⚑ Pharmaceutical
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+25.4% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
46 days to disclose · 1 past 45-day window
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+21.9% vs S&P 500
Trade dateApr 3, 2023
Filed 3.1y ago· Apr 20, 2023
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Amgen
AMGN
$1K-$15K
+16.2% vs S&P 500
Trade dateMar 27, 2023
Filed 3.1y ago· Apr 20, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+26.0% vs S&P 500
Trade dateMar 14, 2023
Filed 3.1y ago· Apr 14, 2023
4 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
Amgen
AMGN
$15K-$50K
+37.0% vs S&P 500
Trade dateApr 10, 2023
Filed 3.2y ago· Mar 17, 2023
22 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+25.1% vs S&P 500
Trade dateFeb 23, 2023
Filed 3.3y ago· Feb 17, 2023
21 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Amgen
AMGN
$1K-$15K
+11.8% vs S&P 500
Trade dateJan 27, 2023
Filed 3.4y ago· Jan 13, 2023
24 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+14.5% vs S&P 500
Trade dateDec 20, 2022
Filed 3.6y ago· Nov 10, 2022
16 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Amgen
AMGN
$1K-$15K
+14.3% vs S&P 500
Trade dateOct 25, 2022
Filed 3.6y ago· Nov 10, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+21.8% vs S&P 500
Trade dateOct 12, 2022
Filed 3.6y ago· Nov 10, 2022
35 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Amgen
AMGN
$1K-$15K
+15.5% vs S&P 500
Trade dateOct 6, 2022
⚑ Pharmaceutical
Filed 3.7y ago· Oct 5, 2022
9 days to disclose
Earl Blumenauer
—HouseOregon-03
↑bought
Amgen
AMGN
$1K-$15K
−44.1% vs S&P 500
Trade dateSep 26, 2022
Filed 3.7y ago· Sep 14, 2022
42 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.8y ago· Sep 2, 2022
401 days to disclose · 356 past 45-day window
Carol D. Miller
RHouseWest Virginia-01
↑bought
Amgen
AMGN
$15K-$50K
−21.6% vs S&P 500
Trade dateJul 28, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+17.6% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Amgen
AMGN
$1K-$15K
+17.6% vs S&P 500
Trade dateJul 27, 2022
Filed 4.0y ago· Jun 16, 2022
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Amgen
AMGN
$1K-$15K
+14.7% vs S&P 500
Trade dateMay 2, 2022
Filed 4.1y ago· Apr 17, 2022
39 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Amgen
AMGN
$1K-$15K
+28.6% vs S&P 500
Trade dateMar 9, 2022
Filed 4.2y ago· Apr 1, 2022
18 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Amgen
AMGN
$1K-$15K
+14.4% vs S&P 500
Trade dateMar 14, 2022
Filed 4.2y ago· Apr 1, 2022
36 days to discloseEarl Blumenauer
—HouseOregon-03
↑bought
Amgen
AMGN
$1K-$15K
+25.5% vs S&P 500
Trade dateFeb 24, 2022
Filed 4.2y ago· Mar 16, 2022
27 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
Amgen
AMGN
$1K-$15K
Trade dateFeb 17, 2022
Filed 4.2y ago· Mar 7, 2022
13 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
−10.6% vs S&P 500
Trade dateFeb 22, 2022
Filed 4.2y ago· Mar 7, 2022
18 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Amgen
AMGN
$1K-$15K
Trade dateFeb 17, 2022
Filed 4.3y ago· Feb 14, 2022
33 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Amgen
AMGN
$1K-$15K
−2.9% vs S&P 500
Trade dateJan 12, 2022
⚑ Pharmaceutical
Filed 4.4y ago· Jan 21, 2022
37 days to discloseShelley Moore Capito
RSenateWest Virginia
↑bought
Amgen
AMGN
$1K-$15K
+5.4% vs S&P 500
Trade dateDec 15, 2021
⚑ Pharmaceutical
Filed 4.4y ago· Jan 15, 2022
31 days to discloseShelley Moore Capito
RSenateWest Virginia
↑bought
Amgen
AMGN
$1K-$15K
+5.4% vs S&P 500
Trade dateDec 15, 2021
⚑ Pharmaceutical
Filed 4.8y ago· Aug 4, 2021
16 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
−28.4% vs S&P 500
Trade dateJul 19, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Amgen
AMGN
$1K-$15K
+27.3% vs S&P 500
Trade dateApr 30, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 27d ago | Maria Elvira Salazar RHouseFlorida-27 | ↓sold | Amgen AMGN | Apr 17, 2026 21 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Apr 21, 2026 1mo ago | Maria Elvira Salazar RHouseFlorida-27 | ↑bought | Amgen AMGN | Mar 24, 2026 28 days to disclose | Bad buy·−$1.7K-5.1% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 6, 2026 3mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Feb 26, 2026 8 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Amgen AMGN | Jan 16, 2026 17 days to disclose | Bad buy·−$69-0.9% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | Amgen AMGN | Nov 19, 2024 420 days to disclose · 375 past 45-day window | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Amgen AMGN | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$402+5.0% +6.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2025 6mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Amgen AMGN | Dec 3, 2025 2 days to disclose | Flat·+0.0% −4.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 28, 2025 7mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Oct 24, 2025 4 days to disclose | Good buy·+$1K+12.8% +11.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 22, 2025 7mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 25, 2025 27 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2025 8mo ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 4, 2025 29 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 27, 2025 8mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Sep 11, 2025 16 days to disclose | Good buy·+$1.3K+16.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Daniel Meuser RHousePennsylvania-09 | ↓sold | Amgen AMGN | Feb 11, 2025 190 days to disclose · 145 past 45-day window | Flat·+0.0% +1.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Good buy·+$1.5K+19.2% +8.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2025 11mo ago | Cliff Bentz RHouseOregon-02 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Energy and Commerce | Jun 6, 2025 33 days to disclose | Good buy·+$1K+12.8% +2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$386+4.8% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Amgen AMGN | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2025 1.0y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 14, 2025 5 days to disclose | Good buy·+$2K+25.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 9, 2025 1.1y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Apr 16, 2025 23 days to disclose | Good buy·+$1.4K+17.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Apr 16, 2025 23 days to disclose | Good buy·+$1.4K+17.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Amgen AMGN | Apr 11, 2025 27 days to disclose | Good buy·+$5.1K+15.6% +7.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 5, 2025 1 day to disclose | Good buy·+$1.4K+17.5% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Amgen AMGN | Feb 24, 2025 13 days to disclose | Good buy·+$2.2K+6.8% +6.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 11, 2025 1.3y ago | Emily Randall DHouseWashington-06 | ↓sold | Amgen AMGN | Jan 6, 2025 36 days to disclose | Flat·+0.0% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.7K+21.3% +18.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2024 1.6y ago | Sheldon Whitehouse DSenateRhode Island | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 17, 2024 23 days to disclose | Missed gain·−$282-3.5% +23.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Good buy·+$3.6K+45.4% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 13 days to disclose | Good buy·+$3.6K+4.8% +3.1% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 2, 2024 18 days to disclose | Flat·-0.4% +1.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 2, 2024 45 days to disclose | Good buy·+$432+5.4% +2.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jan 23, 2024 14 days to disclose | Good buy·+$456+5.7% −0.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Amgen AMGN | Jan 2, 2024 20 days to disclose | Missed gain·−$5.2K-15.9% +35.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 18, 2022 357 days to disclose · 312 past 45-day window | Good buy·+$12.3K+38.0% −28.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 27, 2019 1413 days to disclose · 1368 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 17, 2023 2.9y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jun 12, 2023 35 days to disclose | Missed gain·−$4.7K-58.5% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Apr 28, 2023 21 days to disclose | Good buy·+$2.9K+36.6% +25.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Apr 3, 2023 46 days to disclose · 1 past 45-day window | Good buy·+$2.8K+35.3% +21.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Amgen AMGN | Mar 27, 2023 24 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Mar 14, 2023 37 days to disclose | Good buy·+$3.5K+43.4% +26.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2023 3.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Amgen AMGN | Apr 10, 2023 4 days to disclose | Missed gain·−$12.1K-37.3% +37.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 17, 2023 3.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Feb 23, 2023 22 days to disclose | Good buy·+$3.1K+39.2% +25.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Amgen AMGN | Jan 27, 2023 21 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2023 3.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Dec 20, 2022 24 days to disclose | Good buy·+$2K+24.9% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Amgen AMGN | Oct 25, 2022 16 days to disclose | Flat·+0.0% +14.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Oct 12, 2022 29 days to disclose | Flat·+0.0% +21.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 10, 2022 3.6y ago | Tommy Tuberville RSenateAlabama | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 6, 2022 35 days to disclose | Good buy·+$2.7K+34.1% +15.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2022 3.7y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Amgen AMGN | Sep 26, 2022 9 days to disclose | Good buy·+$4.1K+51.9% −44.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Ways and Means | Jul 28, 2021 401 days to disclose · 356 past 45-day window | Good buy·+$13.3K+41.1% −21.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 27, 2022 14 days to disclose | Good buy·+$2.4K+30.1% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Amgen AMGN | Jul 27, 2022 14 days to disclose | Good buy·+$2.4K+30.1% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 16, 2022 4.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Amgen AMGN | May 2, 2022 45 days to disclose | Flat·+0.0% +14.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Amgen AMGN | Mar 9, 2022 39 days to disclose | Good buy·+$3.4K+42.9% +28.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Amgen AMGN | Mar 14, 2022 18 days to disclose | Flat·+0.0% +14.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Amgen AMGN | Feb 24, 2022 36 days to disclose | Good buy·+$3.4K+42.4% +25.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 16, 2022 4.2y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | Amgen AMGN | Feb 17, 2022 27 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 7, 2022 4.2y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Feb 22, 2022 13 days to disclose | Good buy·+$4.4K+55.6% −10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Amgen AMGN | Feb 17, 2022 18 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 12, 2022 33 days to disclose | Good buy·+$3.9K+48.7% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 21, 2022 4.4y ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 15, 2021 37 days to disclose | Good buy·+$4.6K+57.1% +5.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2022 4.4y ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 15, 2021 31 days to disclose | Good buy·+$4.6K+57.1% +5.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 4, 2021 4.8y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Jul 19, 2021 16 days to disclose | Good buy·+$3.2K+39.6% −28.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Amgen AMGN | Apr 30, 2021 6 days to disclose | Missed gain·−$3.5K-43.8% +27.3% vs S&P 500 | $1K-$15K midpoint $8K |